DNA
Genentech is a leading biotechnology company focused on discovering, developing, and delivering medicines for patients in areas including oncology, neuroscience, and ophthalmology. The company emphasizes breakthrough science and patient-focused support, with programs for enrollment, insurance understanding, and disease education. Based in the United States, Genentech operates as a research-driven biopharmaceutical organization committed to advancing therapies through clinical trials and collaboration with medical professionals and patient communities.
No recent deals for this company.